 SAN DIEGO, March 3, 2022 PRNewswire -- Regulus Therapeutics Inc. Nasdaq: RGLS, a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs the Company or Regulus, today announced that it has scheduled its fourth quarter and year-end 2021 financial results conference call and webcast on Thursday, March 10, 2022, after the U.S. financial markets close. In connection with the earnings release, Regulus management team will host a live conference call and webcast at 5:00 PM ET on Thursday, March 10, 2022, to discuss the Companys financial results and provide a corporate update. 